In a new job - September 10, 2018
She will be in charge of Orion’s oncology research
Johanna Ivaska, Academy Professor of Biochemistry has been appointed Head & Vice President of Oncology Research in Orion Corporation as of 1 October 2018. Ivaska joins Orion from the University of Turku and will continue working also there with her research team. In the role of Head & Vice President of Oncology Research in Orion R&D Ivaska will […]
In a new job - September 1, 2018
Ortivus’ CEO is dismissed
At the Board meeting on August 27, the Board of Ortivus AB has decided to dismiss the Chief Executive Officer Staffan Eriksson from his assignment, effective immediately. The Chief Financial Officer of the company, Lars Höst, has at the same time been appointed acting CEO. Staffan Eriksson has, during his almost two years as CEO […]
In a new job - August 17, 2018
Symcel appoints two new board members
The company has announced the appointment of two new board members, Erik Walldén and Stefan Löfås. Both members will play a key role in bolstering the full execution of the company’s corporate strategy to grow business in the research market and develop much needed solutions for clinical diagnostics, it reports. During 30 years of international […]
In a new job - August 13, 2018
New Chief Scientific Officer at Zelluna Immunotherapy
The Norwegian biotech company has announced the appointment of Namir Hassan as chief scientific officer (CSO). “Namir has gathered extensive scientific knowledge in immunology, and, specifically, T-cell receptor based therapies. His experience spans research through to translational development in biotech and pharma and he has led the growth of research organizations in oncology and infectious […]
In a new job - August 13, 2018
New Chief Medical Officer at Moberg Pharma
Shaw Sorooshian has been appointed as Vice President and Chief Medical Officer of Moberg Pharma. Shaw Sorooshian will during the fall be joining the management team at Moberg Pharma coming from a previous position as Senior Director Global Medical Affairs at Sobi AB. He will be replacing Kjell Rensfeldt in the management team, bringing extensive […]
In a new job - August 9, 2018
Johan Kördel joins Athera’s board
Johan Kördel has been elected as board director in Athera Biotechnologies AB, replacing Lennart Hansson who recently retired from Industrifonden. Professor Gunnar Olsson, former head of AstraZeneca CVD/GI Therapy area remains Chairman of the Board. Otto Skolling and Svein Mathisen remain as board directors for Athera. “We are very pleased to welcome Johan to the […]
